Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Medtronic to announce financial results for its first quarter of fiscal year 2027
-
AIHS and CECC Form Joint Venture to Develop, Invest In, Construct and Operate AI Data Centers in the United States
-
Mentari Therapeutics Appoints Industry Veteran Greg Divis as Chief Executive Officer
-
NN, Inc. Expands Contract Manufacturing of Weapons Components, Secures New Awards with Leading Firearms Provider
-
BioLineRx and Hemispherian AS to Present Data Demonstrating Strong Synergy of GLIX1 with PARP Inhibitors in HR-Proficient Ovarian Cancers at ESMO 2026
-
Major project demands drive construction growth in Nova Scotia to 2035, and may help to offset softening residential activity
-
Mag Instrument (MAGLITE®) Joins Forces with the Pedestrian Safety Institute to Save Kids from Being Killed by Cars, launching The Safer Road Initiative
-
Compugen to Release Second Quarter 2026 Results on Monday, August 3, 2026
-
An aging labour force may create challenges as infrastructure investment dominates New Brunswick’s construction outlook
-
Globe Life Inc. Announces Second Quarter 2026 Earnings Release and Conference Call
-
Redwire Announces Major Expansion in Huntsville, Scaling Production of Combat-Proven UAS and Mission-Critical Space Infrastructure
-
HIGHWAY HOLDINGS OPENS FISCAL 2027 WITH 29% YOY REVENUE GROWTH, 58% YOY GROSS PROFIT GROWTH AND RETURN TO OPERATING PROFITABILITY
-
Knightscope Preliminary Q2 Revenue Triples to Approximately $9M
-
Alkegen Enters Into Restructuring Support Agreement to Eliminate $3.1 Billion of Debt and Strengthen Financial Foundation
-
Mag Instrument (MAGLITE) Joins Forces with Pedestrian Safety Institute to Save Kids from Being Killed by Cars, launching The Safer Road Initiative
-
CONMED Corporation to Participate in the Society of Robotic Surgery Annual Meeting
-
Marengo Secures ESMO 2026 Oral Presentation for Key Phase 2 Invikafusp Alfa Data in PD-1-Resistant Solid Tumors and Appoints Pembrolizumab Development Leader Eric Rubin, M.D., to Scientific Advisory B
-
Hexcel Announces Expanded Long-Term Agreements with Boeing
-
Defense Metals to Present at the Precious Metals & Critical Minerals Virtual Investor Conference on July 22nd
-
Enlightenment Capital Announces Strategic Investment in Quorum
-
Neogen to Release Fourth-Quarter Fiscal Year 2026 Financial Results on July 30, 2026
-
ADM Appoints Jeff Rowe as Executive Vice President and Chief Operating Officer
-
Augurex Abstract Receives ADLM Immunology Abstract Award and Selected for Highlighted ePoster Discussion at ADLM 2026
-
Terex Announces Second Quarter 2026 Financial Results Conference Call
-
HASI Announces Second Quarter 2026 Earnings Release Date and Conference Call
-
Magnolia Oil & Gas Announces Acquisition of WildFire Energy
-
Rising costs outpace sales growth, eroding restaurant profitability, new report finds
-
Mindspace Signs 54,000-Square-Foot Lease at San Francisco’s Iconic Transamerica Complex for Largest U.S. Location
-
CytoSorbents to Report Second Quarter 2026 Financial Results and Recent Business Highlights
-
Agility Bank Appoints Houston Banking Expert Donette T. Stubblefield as New Chief Executive Officer
-
monday.com to Announce Second Quarter 2026 Financial Results on Monday, August 10, 2026
-
AMC Entertainment Attracts More Than 4.3 Million Moviegoers Worldwide as THE ODYSSEY Delivers the Biggest Opening Weekend for an R-rated Film Across AMC’s U.S. Circuit Since 2024
-
Tamboran Successfully Completes Largest Beetaloo Basin Stimulation Program
-
SES AI Receives Continued Listing Standard Notice from NYSE
-
LCI Industries Appoints Robert Hureau to Board of Directors
-
Clinigen Appoints Greg Skalicky as Chief Executive Officer
-
New Episode of Advancements Airing on Saturday, July 25, at 8:00 PM ET
-
Accel Entertainment Adds Approximately 600 Electronic Gaming Terminals in Nevada with Green Valley Grocery Route Agreement
-
Orthofix to Participate in Upcoming Investor Conferences
-
Can-Fite Positive Phase 2a Pancreatic Cancer Study Data Accepted for Presentation at ESMO Congress 2026, One of the World's Premier Scientific Meetings in Oncology
-
OKYO Pharma Announces Filing of Annual Report with Strengthened Cash Position and Accelerated Phase 3 Plans
-
USA Rare Earth Announces Leadership Transition
-
Can-Fite Positive Phase 2a Pancreatic Cancer Study Data Accepted for Presentation at ESMO Congress 2026, One of the World's Premier Scientific Meetings in Oncology
-
Alternative Ballistics Corporation (OTCQB: ALBC) Announces PT Panglima Pandawa Sakti as First International Online Marketplace for The Home Defense™
-
AI Utility Tokens Gain Momentum as Solana Unchained Launches Unchained Wallet Beta With Just 2 Days Left in the Final Presale Phase
-
Destination XL Group, Inc. Files Preliminary Proxy Statement With Respect to FullBeauty Merger
-
AIHS and CECC Form Joint Venture to Develop, Invest In, Construct and Operate AI Data Centers in the United States
-
Gatekeeper Unveils New Visual Identity to Reflect Its Natively Unified Architecture and Agentic Innovation
-
Dmitry Shubov Consulting Warns International Founders Over U.S. Subscription Cancellation Crackdown
-
Iridex Adds EndoProbe® Handpieces to EyeProGPO Product Offering
